OBJECTIVES: Atrial tachyarrhythmias occur in up to 25% of patients after major thoracic surgery. We examined risk factors for newonset atrial fibrillation (AF) following oesophagectomy in an attempt to guide prophylactic use of anti-arrhythmic strategies.
INTRODUCTION
Atrial tachyarrhythmias are a common occurrence after major thoracic surgery. Its incidence adds to pre-existing morbidity and mortality in an increasingly older population of patients undergoing surgery for intra-thoracic malignancy. New-onset atrial arrhythmias are associated with an increased length of stay and mortality after surgery.
The mechanisms underlying the development of postoperative arrhythmias remain unclear. Pain, effect of anaesthetic agents, the use of epidural analgesia, manipulation of intrathoracic organs at surgery, vagotomy, breaching of the pericardial sac, catecholamine surge or hypotensive episodes during surgery, presence of undetected heart disease and cardiac ischaemia in the perioperative period could all potentially contribute to postoperative arrhythmias. There are conflicting reports on the use of pharmacological agents to prevent atrial fibrillation/flutter (AF) following thoracic surgery. The use of beta-blockers and calcium channel blockers has resulted in a reduced rate of AF in selected patients [1] [2] [3] . However, these studies have not demonstrated a reduction in length of stay in hospital or mortality in those patients receiving prophylactic drugs [3, 4] . In addition, there are also no reports on the cost-effectiveness of the use of prophylactic therapy to prevent arrhythmias. The use of prophylactic drugs in all patients undergoing surgery is clearly inappropriate as it exposes several patients to unnecessary treatment and their potential side effects such as tachyarrhythmias, adult respiratory distress syndrome (ARDS) and pulmonary oedema [3, 4] . However, an examination of clinical predictors of post-operative arrhythmia could potentially identify those patients at risk and guide prophylactic use of anti-arrhythmic agents [1, 5, 6] .
MATERIALS AND METHODS

Patients
Patients were identified from a prospectively maintained database of operative procedures performed by the Department of Thoracic Surgery at the Nottingham City Hospital between 1991 and 2010. One thousand and thirty-nine patients were identified to have undergone surgery for resection of an oesophageal malignancy during this period. All patients with pre-operative cardiac arrhythmias were excluded from analyses.
Patients who had a history of angina or myocardial infarction (MI) and were noted to have been treated with drugs or had a history of angioplasty or coronary bypass grafting were recorded on the database as having ischaemic heart disease (IHD).
Patients who developed post-operative AF were compared with the group of patients who remained in sinus rhythm with regard to pre-operative comorbidity, operative course, postoperative complications and long-term survival.
Pre-operative preparation
Patients accepted for surgical excision of cancer had histological confirmation of the diagnosis of cancer. All patients had a computed tomography (CT) scan to stage the tumour. Positron emission tomography scans were not performed on any of the patients. CT scans of thorax and abdomen and laparoscopic examination confirmed the absence of metastatic lesions. All patients had pre-operative lung function tests and an electrocardiography (ECG). Additional tests of cardio-respiratory fitness were only performed if clinically indicated.
Patients were subjected to surgical resection either alone or following neo-adjuvant chemotherapy. Chemotherapy regimen included combinations of 5-fluorouracil and cisplatin. Patients with squamous cell carcinomas are treated with a single dose of cisplatin and capecitabine or 5-fluorouracil administered intravenously for 96 h. Patients with adenocarcinoma are treated with a single dose of epirubicin and cisplatin with 5-fluorouracil (ECF) or epirubicin and cisplatin with twice daily oral doses of capecitabine (ECX) if the patient is able to swallow tablets. Patients with squamous cell carcinoma receive two cycles of this combination, whereas patients with adenocarcinoma are treated with three cycles of a combination regimen administered once every 3 weeks. Patients who did not have chemotherapy were older and therefore more likely to have comorbidities such as renal impairment. After completion of chemotherapy, patients underwent a CT scan of chest, abdomen and pelvis prior to oesophagectomy.
Resection and post-operative care
Resection was achieved through a variety of approaches: left thoracophrenotomy, left thoraco-laparotomy, Ivor-Lewis (laparotomy to mobilize the stomach with a right thoracotomy to mobilize the oesophagus for anastomosis in the chest) or McKeown (laparotomy to mobilize the stomach, right thoracotomy to mobilize the oesophagus followed by anastomosis through a separate incision in the neck). The approach used was dictated by surgeon preference as well as anatomical location of the tumour. All patients underwent en-bloc oesophagectomy as previously described [7] .
Patients were recovered in the intensive care unit rarely more than 24 h following surgery and transferred to step-down care when medically stable. Patients were monitored using central venous catheters, arterial lines and urinary catheter. Epidural catheters were placed routinely for pain relief. It is not our policy to administer anti-arrhythmic agents in an attempt at preventing arrhythmias. Patients were monitored for at least 72 h when any arrhythmias could be diagnosed efficiently. AF was confirmed on a 12-lead ECG and only treated if it persisted for >30 min. Electrolyte disturbances were corrected prior to treatment with either with digoxin or amiodarone. All events of AF occurring after the operative procedure until the time of discharge from hospital were recorded as a post-operative complication. It has not been a routine practice to anticoagulate patients with arrhythmias although all patients receive thromboprophylaxis with subcutaneous low-molecular-weight heparin.
Integrity of the anastomosis was checked in all patients with a contrast swallow between the fifth and seventh post-operative days and if no anastomotic leak was detected radiographically, patients proceeded with a gradually increasing oral intake, advancing to a soft diet prior to discharge from hospital. A nasojejunal feeding tube was used in cases where a leak was demonstrated and if patient returned to theatre, a feeding jejunostomy was performed.
In our practice, patients are kept in hospital until medical condition permits discharge home. Patients seldom required transfer to an intermediate care centre for convalescence and no patient was discharged until oral intake was satisfactory.
Follow-up
Following discharge from hospital, patients are reviewed 6 weeks later and thereafter at 3-monthly intervals in the first year, 6-monthly for the next year and yearly thereafter for at least 5 years. In our practice, a chest X-ray and clinical examination are performed at each clinic visit with additional tests as dictated by development of new symptoms and progress following surgery.
Statistical analyses
Data are presented as median and interquartile range (IQR) for continuous variables, and as number and percentage for discrete variables. Comparisons of continuous variables were made with the Mann-Whitney U-test. Categorical variables were compared with χ 2 -test or Fisher's exact test as appropriate. Stepwise logistic regression was performed to identify independent predictors of the risk of developing arrhythmias. Variables that were significant to a P-value of <0.1 on univariate analysis (advanced age, use of neo-adjuvant chemotherapy, hypertension and IHD) were included in multivariate analysis to identify independent predictors. Age was included as a continuous variable and the others were categorical variables. A receiver operating characteristic (ROC) curve was generated using these independent predictors of arrhythmias following logistic regression analysis [8, 9] . The discrimination ( predictive ability) of the model was determined by measuring the area under the ROC curve (AUC or c-statistic). Discrimination is reflected in a c-statistic ranging from 0.5 (indicating no discriminative ability, reflected by the 45°diagonal in the ROC space in Fig. 1 ) to 1.0 ( perfect discrimination) [10] . Calibration was determined using Hosmer-Lemeshow test for goodness of fit. A P-value of >0.05 indicates a well-calibrated model.
All statistical analyses were performed using SPSS statistical software version 19 (IBM ® SPSS). A P-value of <0.05 was used as a threshold for statistical significance.
RESULTS
Patients (Table 1)
Of the 997 patients without a history of pre-operative arrhythmias included in this analysis, 209 (20.96%) developed atrial arrhythmias in the post-operative period until discharge from hospital and 788 patients remained in sinus rhythm. The patients who developed AF were noted to be older with a median age of 70.54 years (IQR 65-75) vs. 66.9 years (IQR 59-73) (P < 0.01). There was no difference in proportion of males between the two groups (n = 141, 67.4% in the AF group vs. n = 568, 72.08%, P = 0.11). There was also no difference between the groups in the proportion of patients with diabetes mellitus (n = 56, 7.1% in the AF group vs. 23, 11%, P = 0.171). Histories of renal impairment, smoking and of smoking in the 30 days prior to the surgical procedure were similar in both the groups. In addition, the groups were comparable in levels of haemoglobin, serum albumin, pre-operative forced expiratory volume (FEV1), forced vital capacity (FVC) and body mass index. There was a higher proportion of patients with squamous cell carcinomas in the group that developed AF but this did not reach statistical significance (n = 69, 33.01% vs. n = 211; 26.7%, P = 0.171) ( Table 1) . Forty-four patients in the AF group had received neo-adjuvant chemotherapy (21.1%) in comparison to 108 patients (13.7%, P = 0.007) in the group of patients who remained in sinus rhythm.
Post-operative course and complications
The group of patients who developed AF had a higher in-hospital mortality rate (8.1 vs. 4.8%, P = 0.049) and a longer length of hospital stay (median, ±14 days vs. 12 days, P < 0.01). There was no difference between the groups in the incidence of deep venous thrombosis (P = 0.36), stroke (P = 0.36) or anastomotic leak (P = 0.46); a higher incidence of pulmonary embolism was noted in association with AF (1.5 vs. 4.8%, P = 0.008) ( Table 2) . Patients who developed other major complications (ARDS, respiratory failure requiring re-intubation and ventilation, acute coronary syndrome including MI, septicemia and peritonitis) were analysed as a separate subgroup (n = 71). The incidence of AF in this separate population was 35.2% in comparison to a 19.8% incidence in the absence of these complications. The length of hospital stay was 43 days (IQR 18-86) (P < 0.01) and hospital mortality was 36% (P = 0.021) when AF was associated with these complications. Multivariate logistic regression analysis identified advanced age [odds ratio (OR): 1.04; P < 0.01] and the use of neo-adjuvant chemotherapy (OR: 1.92; P < 0.01) to be independent predictors of the risk of developing new-onset AF (Table 3) . Using these two variables, a model was created to predict the risk of AF and an ROC curve was drawn (Fig. 1) . Assessment of discriminative ability ( predictive accuracy) of this model revealed a c-statistic of 0.62. Hosmer-Lemeshow test for goodness of fit returned a P-value of 0.469 (χ 2 = 7.642).
DISCUSSION
Oesophageal carcinoma is a disease of the elderly, and the development of AF in the post-operative period impairs recovery in this population. To the best of our knowledge, this is the largest series of patients undergoing oesophageal resection examined for post-operative AF. Of the 997 patients included in this retrospective analysis, 209 patients (20.1%) developed AF. There were a comparable proportion of males and females (P = 0.11) and, although curiously, a slightly higher proportion of females developed AF (23.6 vs. 19.9% of males; P = 0.11).
The median age in this population was found to be higher than that in other series. In addition, 73.9% of patients were smokers or ex-smokers. This pre-operative profile and the nature of the operative procedure predispose these patients to cardiac complications. Also, patients undergoing oesophagectomy are managed differently from other major thoracic surgery due to 'nil-by-mouth' status till a contrast swallow confirms anastomotic integrity. The withdrawal of cardiac drugs such as beta-blockers during the immediate post-operative period is thus likely to influence the incidence of AF [11, 12] . Identification of the risk factors for AF and its impact could be useful in planning prophylactic therapy. Reports of atrial arrhythmias after major non-cardiac thoracic surgery have reported male gender, history of congestive cardiac failure, peripheral vascular disease, use of intra-operative blood transfusion and increased extent of tumour resection to be predictors of developing atrial arrhythmias [6, 13] . By univariate analysis, we identified advanced age, history of hypertension and neo-adjuvant chemotherapy to be significant predictors of AF. Of these, advanced age and neo-adjuvant chemotherapy independently predicted AF by multivariate logistic regression.
The association of age with an increased risk of developing AF after thoracic surgery is well recognized [5, [14] [15] [16] . Patients subjected to neo-adjuvant chemotherapy have an increased risk of complications including arrhythmias following surgery [17, 18] . Rice et al. [19] noted a 34% risk of atrial arrhythmias in elderly patients receiving pre-operative therapy vs. 18% in the group that underwent oesophageal resection alone. 5-FU and cisplatin used in our practice for oesophageal cancer chemotherapy are known to be associated with cardiotoxicity including chest pain, ST-T wave changes and arrhythmias [20, 21] . 5-FU therapy is known to cause coronary vasospasm but has also been associated with prolongation of the QT interval and increase in atrial arrhythmias [22, 23] . Tsujimoto et al. [24] have demonstrated an enhanced systemic inflammatory response following oesophagectomy in those patients who were subjected to neo-adjuvant chemotherapy. Although factors associated with surgery could themselves trigger an inflammatory response, this was noted to last longer in the group that received neo-adjuvant therapy [24] . The immuno-modulatory effects of chemotherapy, cytokine response, leucocyte function and subclinical effects on respiratory and cardiac function are likely to play a role in increasing the risk of AF. The interplay between tumour biology and chemotherapy could also influence the risk of atrial arrhythmias. The analysis of patients who received chemotherapy and developed AF included 27 patients (26.5%) with adenocarcinoma and 13 patients (36.1%) with squamous cell carcinoma, although this did not reach statistical significance.
In this series, AF was predictive of a prolonged stay in hospital. In our experience, AF occurs in the first week following surgery and, with the overall median length of stay after surgery being 12 days, the prolonged stay in the AF group is unlikely to have been purely due to the need to treat the arrhythmia. It is likely that AF in this situation occurs in the presence of systemic conditions that preclude earlier discharge from hospital. This is consistent with our data showing a higher mortality of 8.1% in the group with AF compared with 4.8% in the other group. Higher mortality is likely to be due to the fact that AF occurs more frequently in association with other major complications rather than due to AF directly affecting mortality.
We did not routinely anti-coagulate patients with AF in the absence of other indications. In this series, atrial arrhythmias were associated with a higher incidence of pulmonary embolism but not stroke or deep venous thrombosis. A recent study on patients developing atrial arrhythmias following thoracic surgery noted that anticoagulation increased risk of bleeding complications but did not reduce the incidence of stroke [25] . In our study, the small absolute numbers of such complications make it hard to draw definite conclusions about thromboembolism risk. In addition, the retrospective nature of this analysis makes it difficult to distinguish between causality and association.
Following non-cardiac major thoracic surgery, AF could occur either as an isolated event or in concert with major complications such as respiratory failure, septicemia, ARDS, MI, etc. Although the precise mechanisms of AF in either of these two situations are yet to be clearly understood, it is likely that AF accompanying major complications is likely to have a greater impact on length of stay and mortality in the post-operative period. New-onset AF in this setting reflects a grim prognosis and is associated with outcomes more adverse than in the absence of these complications. This heterogeneity in the aetiology of AF following oesophagectomy makes it difficult to analyse the effects of prophylactic strategies.
Although age and the use of neo-adjuvant chemotherapy were identified to be predictive of AF, creation of a predictive model using these two variables returned a c-statistic of 0.62 (Fig. 1) , indicating only moderate discriminative ability. Although AF can occur as an isolated event, it is seen to occur with other complications, in a population that has a profile that predisposes it to cardio-respiratory complications. Simple prevention of AF is therefore unlikely to affect either short-term outcomes or long-term survival if the underlying aetiology is not clearly understood. For these reasons, strategies to prevent AF, including the use of prophylactic drugs, are unlikely to be cost-effective.
Finally, it is important to recognize the drawbacks of a retrospective analysis of a database as well as the absence of data relating to blood transfusion, operative time and extent of dissection, the drugs used to treat AF, influence of pain and the use of analgesia. All data were, however, entered into the database prospectively by a dedicated audit officer familiar with the nature of this surgery and post-operative course of patients. However, all patients in this study underwent surgery through a thoracotomy and all surgeons in our unit followed similar post-operative management protocols. The effects of variations in operative approach and post-operative protocols on the incidence of arrhythmias were therefore minimized in this single-centre study.
In conclusion, this study identified age at surgery and the use of neo-adjuvant chemotherapy to be independent predictors of the risk of AF following major thoracic surgery. However, a low predictive ability of a model created with these two predictors as well as the heterogeneous nature of the aetiology of AF due to its association with other complications underlines the need for a clearer recognition of its underlying mechanisms. Our data do not support the use of prophylactic strategies to prevent atrial tachyarrhythmias following oesophageal surgery.
